跳至主要内容
临床试验/NCT06579677
NCT06579677招募中不适用

PRospective Observation on CErebral microvaScular Structure and Function (PROCESS): a Population-based Prospective Cohort Study

Beijing Tiantan Hospital2 个研究点 分布在 1 个国家目标入组 3,500 人开始时间: 2024年10月18日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
3,500
试验地点
2
主要终点
Cerebral small vessel disease

研究概览

简要总结

This is a population-based prospective cohort study, aiming to assess the prevalence, distributional characteristics, and dynamic change of cerebral small vessel dysfunction in a Chinese community population using advanced vascular imaging techniques; meanwhile to investigate the effect of vascular risk factors on cerebral small vessel dysfunction, cardiovascular and cerebrovascular diseases, cognitive dysfunction, and mortality.

详细描述

Brain health is defined as normal brain structure, function and social adaptation and the absence of major brain diseases. Brain health is a lifespan-wide process that can be objectively measured and subjectively perceived and is determined by socio-psycho-biological factors. Currently, neurological disorders are the first cause of healthy life lost and the second leading cause of death globally, with nearly 9 million people dying each year from brain-related diseases.

Prevention of major brain diseases, including stroke and dementia, is first and foremost for brain health management. Notably, cerebral small vessel dysfunction may be an earlier pathologic change for the aforementioned major brain diseases. Cerebral small vessel dysfunction includes increased blood-brain barrier permeability, altered neurovascular coupling, decreased cerebral perfusion, decreased cerebral autoregulation, decreased cerebrovascular reactivity, and altered cerebral resting blood flow. Previous studies have shown that the prevalence of cerebral small vessel dysfunction was as high as 40% to 70% in people with illness but data from the general population remain scarce. Vascular risk factors such as aging, hypertension, diabetes, obesity, dyslipidemia, and insulin resistance have been known as important risk factors for the development of major brain diseases. Whereas, it is unclear whether vascular risk factors will cause these brain diseases through affecting cerebral small vessel function.

Thus, this prospective cohort study aims to assess the prevalence, distributional characteristics, and dynamic change of cerebral small vessel dysfunction, and to investigate the effect of vascular risk factors on cerebral small vessel dysfunction, cardiovascular and cerebrovascular diseases, cognitive dysfunction, and mortality in a Chinese community population.

In this study, a total of 3500 participants aged 50 to 75 years from villages and communities of Daxing District, Beijing will be enrolled using cluster sampling method. All the participants will be interviewed at baseline and followed up for 8 years. Baseline data will be collected through face-to-face interviews by trained interviewers using a standardized questionnaire. Baseline data include demographics, lifestyle, physical activity, medical history, cardiovascular risk factors, dietary habits, medication use, sleep status, novel coronavirus infection. Cognitive function assessment and neuropsychiatric examination will be performed based on various scales such as the Montreal Cognitive Assessment (MoCA) Scale and Mini-Mental State Examination (MMSE) Scale.

Additionally, heart function will be tested using electrocardiogram and color ultrasound. Peripheral vascular examination will be performed to measure ankle-brachial index. Fundus examination will be performed by trained ophthalmologists. Gait and eye movement examination will be performed by trained staff. The body composition will be tested using a body composition analyzer.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
50 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Community-dwelling adults aged 50-75 years;
  • Registered Beijing household residents or residents who can be followed up stably in their own communities for a long period;
  • Subjects with written informed consents.

排除标准

  • Residents with moderate to severe disabilities (MRS ≥3), mental illness, stroke, dementia, and other serious neurological disorders (e.g., encephalitis, Parkinson's disease, epilepsy, brain tumors, and rare genetic diseases of the nervous system);
  • Life expectancy of ≤4 years due to serious diseases such as end-stage cancer;
  • Contraindications to magnetic resonance imaging such as implanted devices (e.g., pacemakers, defibrillators, and others);
  • Residents who are participating in other studies.

结局指标

主要结局

Cerebral small vessel disease

时间窗: 2024-09 to 2032-09

Cerebral small vessel disease will be evaluated using 3.0 T MRI based on imaging markers of asymptomatic cerebral infarction, cerebral microbleeds, lacunar, white matter hyperintensity, enlarged perivascular space, and cerebral atrophy.

Neurovascular coupling

时间窗: 2024-09 to 2032-09

Neurovascular coupling is one of cerebral small vessel function indicators and will be measured by 3.0 T MRI.

Cerebral perfusion

时间窗: 2024-09 to 2032-09

Cerebral perfusion is one of cerebral small vessel function indicators and will be measured by 3.0 T MRI.

Cerebral autoregulation

时间窗: 2024-09 to 2032-09

Cerebral autoregulation is one of cerebral small vessel function indicators and will be measured by transcranial Doppler ultrasonography.

Cerebral resting blood flow

时间窗: 2024-09 to 2032-09

Cerebral resting blood flow is one of cerebral small vessel function indicators and will be measured by transcranial Doppler ultrasonography.

次要结局

  • Composite vascular events(2024-09 to 2032-09)
  • Cognitive impairment measured by the Montreal Cognitive Assessment (MoCA) scale(2024-09 to 2032-09)
  • Cognitive impairment measured by the Mini-Mental State Examination (MMSE) scale(2024-09 to 2032-09)
  • All causes of death(2024-09 to 2032-09)
  • Atherosclerotic plaque in retinal arteries.(2024-09 to 2032-09)
  • Atherosclerotic plaque in craniocarotid arteries.(2024-09 to 2032-09)
  • Other vascular events(2024-09 to 2032-09)
  • Vascular interventions(2024-09 to 2032-09)
  • Mean blood flow velocity in arteries(2024-09 to 2032-09)

研究者

发起方
Beijing Tiantan Hospital
申办方类型
Other
责任方
Principal Investigator
主要研究者

yilong Wang

Professor

Beijing Tiantan Hospital

研究点 (2)

Loading locations...

相似试验